市场概况

The global IVD raw materials market had a value of USD 24.34 十亿 2021, 预计将达到美元 34.25 十亿 2027, 复合年增长率为 5.86% 整个预测期内.

The increasing prevalence of chronic conditions and expanding patient populations are driving the demand for diagnostics and laboratory tests. The market share of antigen and antibody-based tests witnessed significant growth during the COVID-19 pandemic, resulting in its major contribution to the market. It is expected to experience the highest incremental growth of USD 3.92 billion and an absolute growth rate of 44.41% 在预测期内.

The growing trends of point-of-care diagnostics and personalized medicine are significant contributors to the expansion of the IVD raw materials market. Investments in the development and commercial launch of IVD instruments and rapid test kits for diagnosing various infectious diseases, as well as their applications in the research segment, will further propel the market in developed countries.

在 2021, pharma & biotech companies held the largest market share of 62.19% in the global IVD raw materials market. 然而, diagnostic laboratories are expected to witness the highest absolute growth rate of 43.37% 在预测期内.

Vendors offer a wide range of high-quality enzymes that are well-suited for manufacturing diagnostic kits and reagents. Manufacturers are also exploring new enzyme sources from a vast pool of enzymes, optimizing and transforming them into the most suitable enzyme molecules.

市场细分

市场根据多种因素进行细分, 包括产品, 技术, 最终用户, 和地理.

Segmentation Analysis by Product
Antibody & Antigen
Enzymes
Proteins
Biological Buffers
其他的

Segmentation Analysis by Technology
Clinical Chemistry
Immunochemistry
Molecular Diagnostics
其他的

Segmentation Analysis by End-User
Pharma & Biotech Companies
Diagnostic Laboratories
其他的

按地理位置细分
北美 – 我们, 加拿大
欧洲 – 德国, 法国, 英国, 意大利, 西班牙
亚太地区 – 中国, 日本, 印度, 韩国, 澳大利亚
拉美 – 巴西, 墨西哥, 阿根廷
中东 & 非洲 – 南非, 沙特阿拉伯, 火鸡

The IVD raw materials market offers a wide range of products applicable to clinical chemistry methods, enabling the development of rapid tests that provide immediate test results. It is projected that the global IVD raw materials market focused on clinical chemistry will reach a value of USD 12.14 十亿 2027.

Recently, there has been a notable expansion in the presence of private laboratories, particularly in developing countries. This expansion has significantly stimulated the growth of the market. 此外, the prevalence of epidemic and pandemic conditions worldwide has led to an increased demand for standalone reference laboratories. 因此, the global IVD raw materials market focused on diagnostic laboratories is expected to grow at a compound annual growth rate (复合年增长率) 超过 6% 之间 2022 和 2027.

In terms of regional dominance, Europe took the lead in the global IVD raw materials market in 2021, surpassing other regions. Europe is recognized as a mature market that boasts well-developed diagnostic infrastructure in most countries. The presence of advanced healthcare infrastructure in European countries has driven the demand for advanced molecular diagnostics. 此外, the latest trend in the European market is the adoption of point-of-care diagnostics. It is anticipated that the Europe IVD raw materials market will reach a value of USD 11.80 十亿 2027.

竞争格局

Prominent manufacturers of IVD raw materials are placing their focus on proprietary processing techniques that meet the specific requirements of the IVD industry. They aim to provide off-the-shelf IVD raw materials that adhere to their own specifications. These manufacturers consistently allocate resources towards research and development projects aligned with market trends and the demand for general health management. 此外, key players actively pursue strategic acquisitions as part of their inorganic growth strategy, seeking to augment sales and profit margins.

Strategic mergers and acquisitions continue to be crucial competitive strategies employed by key players, allowing them to expand their product offerings, gain access to new technologies, and increase their market share. Vendors also prioritize the development and commercialization of innovative analyzers, COVID-19 PCR rapid test kits, and consumables in order to maintain competitiveness and establish a significant presence in the IVD raw materials market.

Key companies profiled in this report include Aalto Bio Reagents, Fapon Biotech, Fujirebio, Merck KGaA, Hoffmann-La Roche, Thermo Fisher Scientific, ABclonal, BBI Solutions, Beijing Diagreat Biotechnology, Biofootprints Healthcare, BioPorto, Creative Diagnostics, CUSABIO Technology, EUPROTEIN, Eximio Biotec, GenScript ProBio, Getein Biotech, Glentham Life Sciences, HyTest , ImmunoDiagnostics, LGC, Medix Biochemica, Meridian Bioscience, More Diagnostics, MP Biomedicals, Nanjing Okay Biotechnology, Nitto Boseki, OYC Europe, Prahas Healthcare, Promega, ReAgent, Rockland Immunochemicals, Sekisui Diagnostics, SERION Immunologics, Signalway Antibody, Suzhou Yacoo Science, Trina Bioreactives, Watson International, Wuhan Huamei Biotech.

已回答的关键问题

How large is the IVD raw materials market?

The IVD raw materials market is projected to reach USD 34.25 十亿 2027.

What factors contribute to the growth of the IVD raw materials market?

The growth enablers in the IVD raw materials market include an increasing prevalence of infectious and chronic diseases, growing awareness for early diagnosis and disease prevention, and a surge in demand for IVD testing and devices.

Who are the major players in the IVD raw materials market?

The key players in the IVD raw materials market are Aalto Bio Reagents, Fapon Biotech, Fujirebio, Merck KGaA, F. Hoffmann-La Roche, and Thermo Fisher Scientific.

Which region has the largest share in the IVD raw materials market?

Europe holds the largest share in the IVD raw materials market.

What are the significant trends in the IVD raw materials market?

The significant trends in the IVD raw materials market include rising demand for point-of-care PCR diagnostics, personalized medicine, and molecular diagnostics.